Dr. John C. Rhee
Overview
John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors.
Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.
His clinical research consists of co-authoring 15 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Sajid M. Peracha, MD, is a medical oncologist at UPMC Hillman Cancer Center, Uniontown. Dr. Peracha is board-certified in medical oncology, hematology, and internal medicine. He received his medical degree from Sind Medical College in Karachi, India. He completed his residency at Woodhull Medical and Mental Health Center in Brooklyn, N.Y., a fellowship at New York Medical College in Valhalla, N.Y., and bone marrow transplant training at the University of Florida in Gainesville, Fla. Dr. Peracha is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Anemia.
UPMC Hillman Cancer Center
Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant.
UPMC Hillman Cancer Center, Independence Health System
John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa. Dr. Waas is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Protein C Deficiency, Protein S Deficiency, Congenital Antithrombin 3 Deficiency, and Hereditary Resistance to Anti-Vitamin K.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Colorectal CancerDr. Rhee isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Rhee isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Rhee isDistinguished. Learn about Familial Pancreatic Cancer.
- Lung CancerDr. Rhee isDistinguished. Learn about Lung Cancer.
- MesenchymomaDr. Rhee isDistinguished. Learn about Mesenchymoma.
- Pancreatic CancerDr. Rhee isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Rhee isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Appendix CancerDr. Rhee isAdvanced. Learn about Appendix Cancer.
- Bone TumorDr. Rhee isAdvanced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- EGFR Positive Lung CancerDr. Rhee isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Rhee isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Immune ThrombocytopeniaDr. Rhee isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Rhee isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Rhee isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Rhee isExperienced. Learn about Ampullary Cancer.